WELCOME AND GOODBYE
MAINTENANCE IMMUNOSUPPRESSION AFTER RENAL TRANSPLANTATION: IDENTIFY THOSE WHO NEED LITTLE OR LESS
IMMUNOSUPPRESSION IN THE POST-ADAPTATION PERIOD
AUXILIARY LIVER TRANSPLANTATION WITH OR WITHOUT PORTAL BLOOD?
ENGINEERING OF HUMAN VASCULAR AORTIC TISSUE BASED ON A XENOGENEIC STARTER MATRIX
LONG-TERM SURVIVAL OF NONHUMAN PRIMATES RECEIVING LIFE-SUPPORTING TRANSGENIC PORCINE KIDNEY XENOGRAFTS
COMPARISON OF UNIVERSITY OF WISCONSIN AND ST. THOMAS’ HOSPITAL SOLUTIONS ON ENDOTHELIUM-DERIVED HYPERPOLARIZING FACTOR-MEDIATED FUNCTION IN CORONARY MICRO-ARTERIES1
IMPORTANCE OF DONOR-DERIVED LYMPHOCYTES IN THE PROTECTION OF PANCREATICODUODENAL OR ISLET GRAFTS FROM RECURRENT AUTOIMMUNITY
NEUTRALIZATION OF TUMOR NECROSIS FACTOR-α ACTION DELAYS BUT DOES NOT PREVENT LUNG INJURY INDUCED BY ALLOREACTIVE T HELPER 1 CELLS1
IMPORTANCE OF PORTAL FLOW DIVERSION IN EXPERIMENTAL AUXILIARY PARTIAL ORTHOTOPIC LIVER TRANSPLANTATION1
OBLITERATIVE LESIONS IN A HETEROTOPIC BRONCHIAL XENOGRAFT MODEL—A PRELIMINARY STUDY1
PERMANENT LIFE SUPPORT BY KIDNEYS PERFUSED WITH A VITRIFIABLE (7.5 MOLAR) CRYOPROTECTANT SOLUTION1
TRANSPLANTED CRYOPRESERVED ENCAPSULATED PORCINE HEPATOCYTES ARE AS EFFECTIVE AS FRESH HEPATOCYTES IN PREVENTING DEATH FROM ACUTE LIVER FAILURE IN RATS1
ARTERIOSCLEROSIS IN RAT AORTIC ALLOGRAFTS: EARLY CHANGES IN ENDOTHELIAL INTEGRITY AND SMOOTH MUSCLE PHENOTYPE1
AUXILIARY RAT LIVER TRANSPLANTATION WITH PORTAL VEIN ARTERIALIZATION IN ACUTE HEPATIC FAILURE1
LONG-TERM HOST UNRESPONSIVENESS TO ENCAPSULATED XENOGENEIC MYOBLASTS AFTER TRANSIENT IMMUNOSUPPRESSION
NATURAL KILLER CELL- AND MACROPHAGE MEDIATED DISCORDANT GUINEA PIG→RAT XENOGRAFT REJECTION IN THE ABSENCE OF COMPLEMENT, XENOANTIBODY AND T CELL IMMUNITY1 2
THE EFFECT OF IMMUNOSUPPRESSION ON POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN PEDIATRIC LIVER TRANSPLANT PATIENTS
COMBINED LIVER AND KIDNEY TRANSPLANTATION IN CHILDREN
RANDOMIZED, PROSPECTIVE TRIAL OF MYCOPHENOLATE MOFETIL VERSUS AZATHIOPRINE FOR PREVENTION OF ACUTE RENAL ALLOGRAFT REJECTION AFTER SIMULTANEOUS KIDNEY-PANCREAS TRANSPLANTATION1 2
PREVALENCE AND OUTCOME OF INVASIVE FUNGAL INFECTIONS IN 1,963 THORACIC ORGAN TRANSPLANT RECIPIENTS
CMV VIRAL LOAD MEASUREMENTS IN WHOLE BLOOD AND PLASMA - WHICH IS BEST FOLLOWING RENAL TRANSPLANTATION?
CYCLOSPORIN DRUG-INTERACTION-INDUCED RHABDOMYOLYSIS. A REPORT OF TWO CASES IN LUNG TRANSPLANT RECIPIENTS
ADDITION OF ISRADIPINE (LOMIR) RESULTS IN A BETTER RENAL FUNCTION AFTER KIDNEY TRANSPLANTATION: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTI-CENTER STUDY1
SUCCESSFUL SURGICAL SALVAGE OF PANCREAS ALLOGRAFTS AFTER COMPLETE VENOUS THROMBOSIS
EARLY DIAGNOSIS OF BRAIN DEATH IN PATIENTS TREATED WITH CENTRAL NERVOUS SYSTEM DEPRESSANT DRUGS
DONOR-SPECIFIC T-CELL REACTIVITY IDENTIFIES KIDNEY TRANSPLANT PATIENTS IN WHOM IMMUNOSUPPRESSIVE THERAPY CAN BE SAFELY REDUCED1
RANDOMIZED STUDY ON THE CONVERSION OF TREATMENT WITH CYCLOSPORINE TO AZATHIOPRINE OR MYCOPHENOLATE MOFETIL FOLLOWED BY DOSE REDUCTION1
NOVEL SURVEILLANCE AND CURE OF A DONOR-TRANSMITTED LYMPHOMA IN A RENAL ALLOGRAFT RECIPIENT1
LIVING DONOR LIVER TRANSPLANTATION FOR FULMINANT HEPATIC FAILURE1
CROSS-REACTIVE GROUP MATCHING DOES NOT LEAD TO A BETTER ALLOCATION AND SURVIVAL OF DONOR KIDNEYS1
COSTIMULATORY MOLECULES ARE ACTIVE IN THE HUMAN XENOREACTIVE T-CELL RESPONSE BUT NOT IN NATURAL KILLER-MEDIATED CYTOTOXICITY1
PROLONGED ALLOGRAFT SURVIVAL IN ANTI-CD4 ANTIBODY TRANSGENIC MICE
ANALYSIS OF EXPRESSION AND FUNCTION OF THE COSTIMULATORY MOLECULE 4–1BB IN ALLOIMMUNE RESPONSES1
FAS LIGAND-DEFICIENT gld MICE ARE MORE SUSCEPTIBLE TO GRAFT-VERSUS-HOST-DISEASE1
IMMUNE RESPONSE AFTER ADENOVIRAL GENE TRANSFER IN SYNGENEIC HEART TRANSPLANTS: EFFECTS OF ANTI-CD4 MONOCLONAL ANTIBODY THERAPY1
CONVERSION FROM TACROLIMUS TO CYCLOSPORIN IN STABLE RENAL TRANSPLANT PATIENTS: SAFETY, METABOLIC CHANGES, AND PHARMACOKINETIC COMPARISON1
GLUTATHIONE SUPPLEMENTATION DURING COLD ISCHEMIA DOES NOT CONFER EARLY FUNCTIONAL ADVANTAGE IN RENAL TRANSPLANTATION1
BABESIOSIS IN A RENAL TRANSPLANT RECIPIENT ACQUIRED THROUGH BLOOD TRANSFUSION
REVERSIBLE ACUTE RENAL ALLOGRAFT DYSFUNCTION DUE TO GABAPENTIN
REFLEX SYMPATHETIC DYSTROPHY SYNDROME OF THE LOWER LIMBS IN A RENAL TRANSPLANT PATIENT TREATED WITH TACROLIMUS
DONOR ORGAN TRANSMISSION OF VARICELLA ZOSTER DUE TO CARDIAC TRANSPLANTATION
ASSOCIATION OF HUMAN HERPESVIRUS 7 WITH CYTOMEGALOVIRUS DISEASE IN RENAL TRANSPLANT RECIPIENTS1 2
PLASMAPHERESIS: AN EFFECTIVE THERAPY FOR PRIMARY ALLOGRAFT NONFUNCTION AFTER LIVER TRANSPLANTATION
THE IMPACT OF HLA SENSITIZATION AND DONOR CAUSE OF DEATH IN HEART TRANSPLANTATION
ATRIAL CONDUCTION DISTURBANCE AS AN INDICATOR OF REJECTION AFTER CARDIAC TRANSPLANTATION
NEGATIVE IMMUNOHISTOCHEMICAL DETECTION OF CD103 (α E β 7 INTEGRIN) IN THE INFILTRATES OF ACUTE REJECTION IN LIVER AND KIDNEY TRANSPLANTATION
IDIOPATHIC GIANT ESOPHAGEAL ULCERS IN A RENAL TRANSPLANT PATIENT RESPONSIVE TO STEROID THERAPY
FATAL TRANSFER OF MALIGNANT MELANOMA FROM MULTIORGAN DONOR TO FOUR ALLOGRAFT RECIPIENTS1 2
PROSTAGLANDIN E 2 INDUCES EXPRESSION OF P-SELECTIN (CD62P) ON CULTURED HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS AND ENHANCES ENDOTHELIAL BINDING OF CD4-T-CELLS1
POSTTRANSPLANTATION WEIGHT GAIN IS PREDOMINANTLY DUE TO AN INCREASE IN BODY FAT MASS
THE ROLE OF MYCOPHENOLATE MOFETIL IN CHICKENPOX AFTER RENAL TRANSPLANTATION
ORGAN DONORS WITH PRIMARY CENTRAL NERVOUS SYSTEM TUMOR1
QUESTIONS ABOUT THE USE OF ORGAN DONORS WITH TUMORS OF THE CENTRAL NERVOUS SYSTEM1 2
COMMENTARY
COMMENTARY
ANNOUNCEMENTS